Phase 1b Study of CS-7017 in Combination With Carboplatin/Paclitaxel in Chemotherapy-naive Subjects With Metastatic or Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2011
At a glance
- Drugs Carboplatin; Efatutazone; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 11 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jul 2011 Last checked against ClinicalTrials.gov record.
- 08 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.